GM x 3 = A great start to the day.
The Curve Finance founder, Michael Egorov, is swimming in some deep water. Yours truly briefly discussed the situation in yesterday's newsletter, but let's dive in deeper.
By now, Egorov's loans taken out against CRV collateral, currently totaling ~$87M, have become infamous within the degen crypto community. These loans have returned to haunt him once again as Curve was hacked yesterday, with over $70M of tokens drained, although some of these tokens were obtained by whitehat hackers and MEV bots. Nevertheless, this naturally led to the CRV price plummeting, down ~20% since the exploits started.
As the collateral value decreases relative to the loan value, Egorov moves closer to liquidation. Currently, the position comprises an Aave v2 loan totaling ~$54M, ~$14M of loans open on Abracadabra, a ~$9M loan on Fraxlend, a ~$9M loan on Inverse, and a ~$1M loan on Silo, all of which are open against CRV collateral. In aggregate, Egorov has borrowed ~$87M against ~400M CRV, valued at ~$235M at the moment. The CRV collateral accounts for ~44% of the circulating supply.
The Curve hacker(s) possesses ~$4.2M CRV and likely can't sell the tokens through CEXs due to KYC restrictions. This means that they would have to dump tokens onchain, and currently, the market depth for CRV is poor as the CRV/ETH pool on Curve was exploited. Most of the CRV onchain liquidity is located in Uniswap v3 on Ethereum, and the TVL across pools where the hacker(s) could reasonably exit their CRV position to liquid assets is ~$5.5M. Simply put, if the hacker(s) were to sell their position, the price impact would be huge. Even on CEXs, the liquidity is nothing to celebrate. On Binance, where most CRV volume occurs, the (2%) depth is at ~$550K.
Since market participants know that onchain liquidity is thin and Egorov could be in trouble, this creates reflexivity where investors dump tokens and short perps, which causes the price to decrease more, leading to the loan position becoming more dangerous, causing more investors to sell, etc. If Egorov defaults on one of his loans, he'll likely default on the rest of them as well since the CRV collateral would have to be liquidated, meaning that sell pressure would be coming from both anticipating investors as well as the liquidators.
Most of Egorov's capital is most likely tied up in illiquid assets, and it's clear that he's struggling to get his hands on capital that he can use to pay down his debt. Most recently, the Curve founder has started doing over-the-counter ("OTC") CRV deals by withdrawing collateral from Aave and quickly paying down the position once he has been paid for the associated OTC deal. As of 7 AM (EST), ~39.3M CRV has been sold OTC against ~15.8M USDT, implying a blended OTC price of ~$0.4.
The aforementioned, together with a fFRAX/crvUSD Curve pool (see Chart of the Day) deployed by Egorov, have successfully stabilized the situation for now. Currently, the liquidation price on the Aave v2 loan is ~$0.36, while it's ~$0.32 on Fraxlend. If you ask me, Egorov's loans will survive to see another day, but this likely isn't the last time the loans cause havoc in the space.
– Brick
No comments:
Post a Comment